Protara Therapeutics, Inc. (TARA) Operating income 2016–2025
Protara Therapeutics, Inc. (TARA) annual operating income history from SEC filings — each fiscal year as reported.
-$64.5MFY2025 · since FY2016: -$28.7M → -$64.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.5M | -31.3% |
| FY2024 | -$49.2M | -12.7% |
| FY2023 | -$43.6M | +35.0% |
| FY2022 | -$67.1M | -41.2% |
| FY2021 | -$47.5M | -37.9% |
| FY2020 | -$34.4M | -339.9% |
| FY2019 | -$7.8M | +63.4% |
| FY2018 | -$21.4M | +29.6% |
| FY2017 | -$30.4M | -5.8% |
| FY2016 | -$28.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice